FDA Updates for the Week of Jan. 9, 2023
FDA Updates for the Week of Jan. 9, 2023 unknown
FDA approves Rybelsus for first-line treatment of diabetes.
The FDA
Omada partners with Intermountain to expand access to its diabetes programs
Intermountain and Castell, its value-based care subsidiary, will refer diabetic patients to Omada
Omada Health is a company that seeks
Alphabet's healthcare unit to sunset some projects, restructure leadership
Verily, the healthcare unit of parent company Alphabet, formerly known as Google, is sunsetting some of its healthcare projects and
Why direct primary care may be the future, and what technology is ...
Homebound patients often struggle with complex medical conditions among the most costly in healthcare. Further, they typically face health equity
Merger and acquisition revenues for health systems hit $45B in 2022
Merger and acquisition revenues for health systems hit $45B in 2022 Jeff Lagasse
Photo: Martin Barraud/Getty Images
The fourth
Telehealth utilization declined almost 4% nationally last fall
Telehealth utilization declined almost 4% nationally last fall Jeff Lagasse
Photo: Kilito Chan/Getty Images
In October 2022, after three
Medicare Begins to Rein In Drug Costs for Older Americans
Medicare Begins to Rein In Drug Costs for Older Americans Paula Span Reforms embedded in the Inflation Reduction Act will
STAT+: Oscar Health’s CEO on post-hype health insurance and finally turning a profit
STAT+: Oscar Health’s CEO on post-hype health insurance and finally turning a profit Bob Herman
Oscar Health has excelled
Improving Electronic Health Records (EHRs): Innovative companies tackling the challenge
Improving Electronic Health Records (EHRs): Innovative companies tackling the challenge Rachel Marley
“By computerizing health records, we can avoid dangerous
Huma acquires Alcedis to expand clinical trial platform
Huma acquires Alcedis to expand clinical trial platform unknown
Digital health tech company Huma acquired clinical trial data specialist Alcedis,